Figure (Atorvastatin Calcium Figure 1)
Atorvastatin Calcium
Product Images NDC 53002-2440
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 53002-2440). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure (Atorvastatin Calcium Figure 2)
This appears to be a graph displaying the cumulative hazard percentages for a placebo and a medication named Atorvastatin. There is also information about the Hazard Ratio and the time to the primary endpoint over four years.*
Figure (Atorvastatin Calcium Figure 3)
This is a data representation of the percentage of subjects who experienced a major cardiovascular endpoint over time when taking either 10mg or 80mg of Atorvastatin. The results show a significant reduction in the occurrence of the event with an Atorvastatin dose of 80mg compared to 10mg. The data suggests that Atorvastatin may be useful in reducing cardiovascular events in high-risk patients.*
Chemical Structure (Atorvastatin Calcium Structure)
Label Image (Lbl530022440)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
